Free Trial

Oak Thistle LLC Acquires New Shares in Azenta, Inc. (NASDAQ:AZTA)

Azenta logo with Medical background

Oak Thistle LLC bought a new stake in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The fund bought 18,544 shares of the company's stock, valued at approximately $927,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Farther Finance Advisors LLC raised its stake in Azenta by 20.0% during the third quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company's stock worth $74,000 after acquiring an additional 256 shares in the last quarter. Benjamin F. Edwards & Company Inc. grew its holdings in shares of Azenta by 150.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company's stock worth $84,000 after purchasing an additional 955 shares during the last quarter. Net Worth Advisory Group acquired a new stake in shares of Azenta during the 3rd quarter worth about $205,000. Aigen Investment Management LP bought a new position in Azenta during the 3rd quarter valued at about $214,000. Finally, Sanctuary Advisors LLC acquired a new position in Azenta in the second quarter valued at about $222,000. Institutional investors own 99.08% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on AZTA shares. Needham & Company LLC dropped their price objective on shares of Azenta from $69.00 to $55.00 and set a "buy" rating for the company in a report on Wednesday, November 13th. Stephens reaffirmed an "overweight" rating and set a $60.00 price target on shares of Azenta in a report on Thursday, January 2nd. Finally, Evercore ISI cut their price objective on Azenta from $53.00 to $50.00 and set an "in-line" rating for the company in a research report on Tuesday, October 1st. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $61.60.

Read Our Latest Stock Analysis on AZTA

Azenta Trading Up 1.3 %

Shares of AZTA traded up $0.70 during mid-day trading on Thursday, hitting $53.00. 319,590 shares of the company traded hands, compared to its average volume of 381,464. The stock has a market capitalization of $2.42 billion, a price-to-earnings ratio of -17.85 and a beta of 1.47. The business has a 50-day moving average of $47.60 and a 200 day moving average of $49.00. Azenta, Inc. has a one year low of $38.82 and a one year high of $69.16.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings data on Tuesday, November 12th. The company reported $0.18 EPS for the quarter, topping analysts' consensus estimates of $0.10 by $0.08. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. The firm had revenue of $170.00 million during the quarter, compared to analyst estimates of $169.66 million. During the same period last year, the company earned $0.13 earnings per share. The company's revenue was down 1.2% on a year-over-year basis. As a group, analysts anticipate that Azenta, Inc. will post 0.41 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO John Marotta bought 12,717 shares of the firm's stock in a transaction dated Monday, November 18th. The stock was bought at an average cost of $39.48 per share, for a total transaction of $502,067.16. Following the transaction, the chief executive officer now owns 99,612 shares of the company's stock, valued at $3,932,681.76. This represents a 14.63 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director William L. Cornog purchased 12,500 shares of the business's stock in a transaction that occurred on Monday, November 18th. The stock was purchased at an average price of $39.60 per share, for a total transaction of $495,000.00. Following the completion of the transaction, the director now directly owns 14,755 shares in the company, valued at $584,298. This trade represents a 554.32 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders sold a total of 1,423 shares of company stock valued at $57,020 over the last ninety days. Insiders own 10.62% of the company's stock.

Azenta Profile

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Read More

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Transportation Stocks to Watch in 2025: Top Picks for Growth
Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines